FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2588 June 19, 2003 Number 25

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Staudt, L. M.

Molecular Diagnosis of the Hematologic Cancers . On page 1780, the sentence beginning on line 4 of the left-hand column should have read "The quartile of patients with the lowest level of proliferation-signature expression had a median survival of 6.7 years, whereas the quartile with the highest level of expression had a median survival of 0.8 year," rather than "highest" and "lowest," respectively, as printed.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.